Aripiprazole in anorexia nervosa and low-weight bulimia nervosa: case reports. 2011

Mary Ellen Trunko, and Terry A Schwartz, and Vikas Duvvuri, and Walter H Kaye
Department of Psychiatry, University of California San Diego, San Diego, California, USA.

OBJECTIVE There has been much interest in the use of atypical antipsychotics in anorexia nervosa (AN). However, newer, more weight-neutral medications have not been studied in AN, and there are no reports of the use of antipsychotics in bulimia nervosa (BN). METHODS We report on the treatment of eight patients (five with AN and three with BN) with aripiprazole for time periods of four months to more than three years. RESULTS All individuals had reduced distress around eating, fewer obsessional thoughts about food, weight and body image, significant lessening of eating-disordered behaviors, and gradual weight restoration where appropriate. Depression, generalized anxiety, and cognitive flexibility improved as well. CONCLUSIONS In summary, these findings support the need to perform controlled trials of aripiprazole in AN and BN.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068180 Aripiprazole A piperazine and quinolone derivative that is used primarily as an antipsychotic agent. It is a partial agonist of SEROTONIN RECEPTOR, 5-HT1A and DOPAMINE D2 RECEPTORS, where it also functions as a post-synaptic antagonist, and an antagonist of SEROTONIN RECEPTOR, 5-HT2A. It is used for the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER, and as an adjunct therapy for the treatment of depression. 7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone,Abilify,Aripiprazol,OPC 14597,OPC-14597
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000856 Anorexia Nervosa An eating disorder that is characterized by the lack or loss of APPETITE, known as ANOREXIA. Other features include excess fear of becoming OVERWEIGHT; BODY IMAGE disturbance; significant WEIGHT LOSS; refusal to maintain minimal normal weight; and AMENORRHEA. This disorder occurs most frequently in adolescent females. (APA, Thesaurus of Psychological Index Terms, 1994) Anorexia Nervosas,Nervosa, Anorexia,Nervosas, Anorexia
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major
D015363 Quinolones A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID. Ketoquinoline,Ketoquinolines,Oxoquinoline,Oxoquinolines,Quinolinone,Quinolinones,Quinolone

Related Publications

Mary Ellen Trunko, and Terry A Schwartz, and Vikas Duvvuri, and Walter H Kaye
July 1987, Archives of surgery (Chicago, Ill. : 1960),
Mary Ellen Trunko, and Terry A Schwartz, and Vikas Duvvuri, and Walter H Kaye
November 1989, The Practitioner,
Mary Ellen Trunko, and Terry A Schwartz, and Vikas Duvvuri, and Walter H Kaye
May 1989, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
Mary Ellen Trunko, and Terry A Schwartz, and Vikas Duvvuri, and Walter H Kaye
September 1992, Behaviour research and therapy,
Mary Ellen Trunko, and Terry A Schwartz, and Vikas Duvvuri, and Walter H Kaye
January 2022, The International journal of eating disorders,
Mary Ellen Trunko, and Terry A Schwartz, and Vikas Duvvuri, and Walter H Kaye
April 1982, Archives of general psychiatry,
Mary Ellen Trunko, and Terry A Schwartz, and Vikas Duvvuri, and Walter H Kaye
January 2000, Annual review of medicine,
Mary Ellen Trunko, and Terry A Schwartz, and Vikas Duvvuri, and Walter H Kaye
January 1995, Ryoikibetsu shokogun shirizu,
Mary Ellen Trunko, and Terry A Schwartz, and Vikas Duvvuri, and Walter H Kaye
January 1986, Annual review of public health,
Mary Ellen Trunko, and Terry A Schwartz, and Vikas Duvvuri, and Walter H Kaye
October 1989, Suomen hammaslaakarilehti = Finlands tandlakartidning,
Copied contents to your clipboard!